Results for this period
Interim period (second quarter)1 April 2026–30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Progress was made in restructuring the cost structure, including selling, general and administrative expenses, and, particularly in the Financial Business, reductions in selling, general and administrative expenses associated with the group reorganization resulted in a shift to an operating profit. In the Wellness Business, increased sales of systems, growth in the loan balance and membership of the early payment service for medical care reimbursements, an increase in the number of hospitals adopting IFMC., and the closing of large-scale deals contributed to higher revenue. These gains were offset by lower equipment sales, a decline in M&A brokerage fee revenue from the previous year, and the disappearance of revenue from financial product intermediary services (IFA) in the Financial Business.
None
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026–30 September 2026 |
| Net Sales | ¥1,302 million (YoY +0.8%) |
| Operating profit | ¥79 million |
| Ordinary income | ¥59 million |
| Profit attributable to owners of the parent | ¥19 million |
| Net income per share | ¥12.02 |
| Equity ratio | End of the current fiscal period 10.9 / End of previous period 7.1 |
| Total assets | ¥2,600 million |
| Net assets | ¥285 million |
| Cash flows from operating activities | ¥7,396 thousand |
| Cash flows from investing activities | ¥-1,111 thousand |
| Cash flows from financing activities | ¥-50,508 thousand |
| Cash and cash equivalents at end of period | ¥1,108,994 thousand |
| Full-year earnings forecast | Net Sales ¥2,502 million (YoY +3.4%) / Operating profit ¥85 million / Ordinary income ¥51 million / Profit attributable to owners of the parent ¥2 million |
| Revision to Earnings Forecast | Not disclosed → Net Sales ¥2,502 million (YoY +3.4%) / Operating profit ¥85 million / Ordinary income ¥51 million / Profit attributable to owners of the parent ¥2 million |
| Annual Dividend Forecast | ¥0 → ¥0（0.0%） |
| Segment revenue | Wellness ¥990,668 thousand (YoY +4.2%) / Financial Business ¥311,606 thousand (YoY -8.4%) |
| Segment profit | Wellness ¥71,631 thousand (YoY +118.8%) / Financial Business ¥7,589 thousand |
| Depreciation and amortization | ¥14,900 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥136 thousand, Gain on transfer of business ¥5,660 thousand, Contract payments ¥10,000 thousand / Extraordinary loss Settlement payment ¥32,887 thousand |
| Disclosure regarding the going concern assumption | None |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | None |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 1,711,800 |
| Treasury Shares at Period-End | 19,239 |
| Factors Behind Changes in Business Performance | Progress was made in restructuring the cost structure, including selling, general and administrative expenses, and, particularly in the Financial Business, reductions in selling, general and administrative expenses associated with the group reorganization resulted in a shift to an operating profit. In the Wellness Business, increased sales of systems, growth in the loan balance and membership of the early payment service for medical care reimbursements, an increase in the number of hospitals adopting IFMC., and the closing of large-scale deals contributed to higher revenue. These gains were offset by lower equipment sales, a decline in M&A brokerage fee revenue from the previous year, and the disappearance of revenue from financial product intermediary services (IFA) in the Financial Business. |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This was due to progress in restructuring the cost structure, including selling, general and administrative expenses, and, particularly in the Financial Business, the segment's shift to an operating profit as a result of reductions in selling, general and administrative expenses associated with the group reorganization.